A. Nascimbeni

Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?

Luigi Fulizio, A. Nascimbeni, Marco Spinazzi et al. · Human Mutation · 2004 · 113 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Frequency of <i>LGMD</i> gene mutations in Italian patients with distinct clinical phenotypes

A. Nascimbeni, Stefania Aurino, Elisabetta Tasca et al. · Neurology · 2009 · 94 citations

Medicine, Genetics, Molecular Genetics +16

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)

C. Angelini, Lucia Nardetto, C. Borsato et al. · Neurological Research · 2010 · 68 citations

Medicine, Neurology, Pathology +17

Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of <i>CAPN3</i> gene mutations

A. Nascimbeni, C. Angelini · Journal of Medical Genetics · 2006 · 46 citations · Full text

Life Sciences, Biochemistry, Genetics +17

Effects of short‐to‐long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)

Michela Ripolone, Raffaella Violano, Dario Ronchi et al. · Neuropathology and Applied Neurobiology · 2017 · 34 citations · Full text

Medicine, Biochemistry, Pathology +15